clinical trial
Aadi Bioscience Inks NGS Lab Partnerships to Screen Solid Tumor Patients for Fyarro Trial
The firm has partnered with Foundation Medicine, Tempus, and others to ID patients with TSC1 and TSC2 mutations for the Phase II PRECISION 1 clinical trial. Â
Stakeholders are working to harmonize strategies for overcoming the challenges faced by new blood-based multi-cancer early detection assays.
Roche, Bristol Myers Squibb Partner on Digital Pathology Algorithms, Assays for Cancer Diagnosis
Under the collaboration, Roche is developing an artificial intelligence-based image analysis algorithm to help pathologists interpret its Ventana PD-L1 (SP142) Assay.
Illumina, French Hospitals Partner on Cancer Genomic Profiling Study
The study will compare Illumina's TruSight Oncology 500 assay to the standard of care for therapy selection in up to 400 cancer patients.
Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing
The companies will provide help with clinical drug trials and companion diagnostics projects that need a China arm for global or China-focused trials.